{
	"kj8twmajText": "Differ<span class=\"_ _0\"></span>ence in mean change from baseline",
	"kj8twmakText": "(Brintellix® vs. placebo)",
	"kj8twmalText": "Symptoms",
	"kj8twmamText": "Depressive symptoms ",
	"kj8twmanText": "(MADRS)",
	"kj8twmaoText": "Anxiety",
	"kj8twmapText": "(HAM-A total)",
	"kj8twmaqText": "F<span class=\"_ _0\"></span>unctioning",
	"kj8twmarText": "F<span class=\"_ _0\"></span>unctioning ",
	"kj8twmasText": "(SDS)",
	"kj8twmatText": "HRQoL",
	"kj8twmauText": "Health-related QoL",
	"kj8twmavText": "(SF-36)",
	"kj8twmawText": "Mean change from baseline a<span class=\"_ _0\"></span>t week 48",
	"kj8twmaxText": "Brintellix® 20mg showed significant reduction in anxiety (HAM-A) at week 6-8 in all patients and pa<span class=\"_ _0\"></span>tients with any trauma<br><span class=\"fsd ws1c\">†</span><span class=\"v6\">As measured by MADRS, HAM-A,<span class=\"_ _0\"></span> SDS, SF-36; *p&lt;0.05.<br>MADRS,<span class=\"_ _0\"></span> Montgomery-Åsberg Depression Rating Scale; HAM-A,<span class=\"_ _0\"></span> Hamilton Anxiety Rating Scale; SDS,<span class=\"_ _0\"></span> Sheehan Disability Scale; HRQoL, Health-Related Quality of Life; <br>SF-36,<span class=\"_ _0\"></span> 36-Item Short Form Health Survey<span class=\"_ _2\"></span>.</span>",
	"kj8twmayText": "P<span class=\"_ _0\"></span>atients with any <br>trauma (n=198)",
	"kj8twmazText": "P<span class=\"_ _0\"></span>atients with childhood <br>trauma (n=104)",
	"kj8twmb0Text": "P<span class=\"_ _0\"></span>atients with recent <br>trauma (n=164)",
	"kj8twmb1Text": "F<span class=\"_ _0\"></span>or p<span class=\"_ _0\"></span>atie<span class=\"_ _0\"></span>nts with MDD w<span class=\"_ _0\"></span>ho ha<span class=\"_ _0\"></span>d <br><span class=\"ls11 ws2b\">experien<span class=\"_ _0\"></span>ced t<span class=\"_ _1\"></span>rauma,<span class=\"_ _1\"></span> Brintellix® demons<span class=\"_ _1\"></span>t<span class=\"_ _1\"></span>rated<br><span class=\"ls0 wsa\">ef<span class=\"_ _1\"></span>fica<span class=\"_ _0\"></span>c<span class=\"_ _1\"></span>y acro<span class=\"_ _0\"></span>ss a ra<span class=\"_ _0\"></span>nge of o<span class=\"_ _0\"></span>utco<span class=\"_ _0\"></span>me<span class=\"_ _0\"></span>s<span class=\"_ _2\"></span><span class=\"fs2 v1\">1</span></span></span>",
	"kj8twmb2Text": "Long-term tr<span class=\"_ _0\"></span>eatment with Brintellix® significantly improved depr<span class=\"_ _0\"></span>essive and anxiety symptoms and overall <br>functioning, as well as lower<span class=\"_ _0\"></span>ed risk of relapse<span class=\"fsf v3\">† </span>among MDD patients with a history of trauma<span class=\"fsf v3\">1</span>",
	"kj8twmb3Text": "Zoom",
	"Brintellix_544046e1fa": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 16px;\">\n\tSymptoms\n</font>\n</span>",
	"Brintellix_54bbe5bf1e": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 16px;\">\n\tFunctioning\n</font>\n</span>",
	"Brintellix_5450ed1952": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 16px;\">\n\tHRQoL\n</font>\n</span>",
	"Brintellix_54b49e89a1": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\">\n<font style=\"font-size: 16px;\">\n\tDifference in mean change from baseline<br><div style=\"text-align: center;\">(Brintellix® vs. placebo)</div></font></span>",
	"Brintellix_547e116b3e": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\"><div style=\"text-align: center;\">Health-related QoL&nbsp;</div>\n<font style=\"font-size: 16px;\"><div style=\"text-align: center;\">(SF-36)</div></font></span>",
	"Brintellix_540a8e91e9": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\"><div style=\"text-align: center;\">Functioning</div>\n<font style=\"font-size: 16px;\"><div style=\"text-align: center;\">(SDS)</div></font></span>",
	"Brintellix_548520104d": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\"><div style=\"text-align: center;\">Depressive</div>\n<font style=\"font-size: 16px;\"><div style=\"text-align: center;\">symptoms (MADRS)</div></font></span>",
	"Brintellix_54adf000c3": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 14px;\">\n\tPatients with any trauma<br>(n=198)\n</font>\n</span>",
	"Brintellix_54f66285ac": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 14px;\">\n\tPatients with childhood trauma<br>(n=104)\n</font>\n</span>",
	"Brintellix_54bd55a06e": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 14px;\">\n\tPatients with recent trauma<br>(n=164)\n</font>\n</span>",
	"Brintellix_54630eeba9": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); line-height: 1;display:block;\"><div style=\"text-align: center;\">Anxiety</div>\n<font style=\"font-size: 16px;\"><div style=\"text-align: center;\">(HAM-A total)</div></font></span>",
	"Brintellix_5416f37e23": "<span style=\"font-family: &quot;3_CCMVBT+AvenirNextLTPro-Demi&quot;; color: rgb(84, 122, 129); \">\n<font style=\"font-size: 25px;\">References</font>\n</span>",
	"Brintellix_541da21de1": "<span style=\"font-family: &quot;2_PIDSIJ+AvenirNextLTPro-Regular&quot;; line-height: 1; color: rgb(100, 94, 94); display: block;\">\n<font style=\"font-size: 15px;\">\n\t<b>1.</b> Christensen MC et al. J Affect Disord 2020;263:258-266.\n</font>\n</span>",
	"Brintellix_54f255b20c": "Text",
	"Brintellix_54a56addf9": "Text",
	"Brintellix_541565ea22": "Text",
	"Brintellix_54ae461ae6": "Text",
	"Brintellix_540243beaa": "Text",
	"Brintellix_54ea25e8c2": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4.5px 22px;line-height:1.1;background-color: #e5f0f2;\">Emotional<br>Blunting</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 30px 11px;line-height:1.1;background-color: #e5f0f2;\">High anxiety</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 13px 45px 11px;line-height:1.1;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">Trauma</div>\n</div>",
	"Brintellix_54c111d824": "<div style=\"font-family: serif;font-family: '2_VDWFON+AvenirNextLTPro-Demi';font-size: 13px;background-color: #e5f0f2;box-sizing: border-box;color: #4d7f86;\">\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 52.5px 2px;line-height:1.3;background-color: #e5f0f2;\">Dose</div>\n\t<div style=\"float: left;text-align: center;border-left: 1px solid #fff;padding: 4px 38px 2px;line-height:1.3;background-color: #e5f0f2;color: #fff;background: rgb(233,90,0);background: linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);background: -webkit-linear-gradient(90deg, rgba(233,90,0,1) 0%, rgba(240,125,0,1) 100%);\">Symptoms</div>\n</div>"
}
